Selective Estrogen Receptor Modulators (SERMs) can be a cornerstone of pharmaceutical PCT interventions. They perform as aggressive inhibitors at estrogen receptors within the hypothalamus while exhibiting tissue-selective agonist or antagonist Attributes through the overall body. SERMs are important in regulating post cycle estrogen creation and m